Twitter | Search | |
Aju Mathew
Cancer doctor, global health researcher, teacher. Sr consultant @ Welcare Kochi, & MOSC Med Coll, India. Faculty @ U Kentucky & @ Manipal. Directs KeralaCanCare
6,696
Tweets
466
Following
1,769
Followers
Tweets
Aju Mathew 3h
How could multiple companies launch herceptin imitators in india without facing law suits? Did Roche close their eyes on the India market? 15% reduced list price is a HUGE LET DOWN.
Reply Retweet Like
Aju Mathew 3h
Reply Retweet Like
Aju Mathew retweeted
Brian Wallach Jul 16
Imagine being told that you have Amyotrophic Lateral Sclerosis. You are a neurologist so you know exactly what that means. You will die. Quickly. And painfully.
Reply Retweet Like
Aju Mathew 10h
Deeply embarassing report. On a related note, it shows the importance of collecting health data at a local and regional level. Not just national.
Reply Retweet Like
Aju Mathew 20h
Can you believe it? 30% of asymptomatic breast cancer survivors in the US gets serum biomarker testing.
Reply Retweet Like
Aju Mathew Jul 17
I had written up something about that. Pls see -
Reply Retweet Like
Aju Mathew Jul 17
This is my take on the complex ethical situation framed by Dr H Bawaskar and shared by his son,
Reply Retweet Like
Aju Mathew Jul 16
Have no experience with using it. I know that it is prognostic. But we don’t know whether it’s predictive of chemo benefit. I believe ESMO recognizes it as equal to oncotypeDX.
Reply Retweet Like
Aju Mathew Jul 16
A critique on the costing of oncotypeDX in india. If they reduce the cost from Rs 2,00,000 to Rs 50,000, there will be many, many, many takers. Is anyone listening?
Reply Retweet Like
Aju Mathew Jul 16
Replying to @ESchattner
😀 WhatsApp. A perennial source of fun, gossip, slander, fake news, and more.
Reply Retweet Like
Aju Mathew Jul 16
this one’s for you. History of lymphoma in one image. - for your future ‘history’ episode.
Reply Retweet Like
Aju Mathew Jul 16
Sorry. If anyone knows, it will be or
Reply Retweet Like
Aju Mathew Jul 15
I know of at least two NCI cancer center doctors (one at NCI and other at an NCI affiliated) who are associated with predatory journals as editors. And they proudly flaunt it. Clearly, scientists are as gullible regarding research as non-scientists.
Reply Retweet Like
Aju Mathew Jul 14
"To err is human. To err repeatedly is research. To err and get error bars on the error is called publication." - Anonymous
Reply Retweet Like
Aju Mathew Jul 14
We just need more people like the ones at this bus stop. Stand up against bullies.
Reply Retweet Like
Aju Mathew Jul 14
He’s truly a passionate activist-doctor. I was super impressed with his ability to bring people together for the greater common good - saw it first hand when I participated in the NCG meeting in March.
Reply Retweet Like
Aju Mathew Jul 14
What? Lung cancer overdiagnosis? Never ever thought I’d use the words in one sentence. What am I missing?
Reply Retweet Like
Aju Mathew Jul 13
Very insightful. Thanks for sharing.
Reply Retweet Like
Aju Mathew retweeted
Dinesh S. Thakur Jul 13
How about starting with “intelligence” and “common sense” before considering AI?
Reply Retweet Like
Aju Mathew retweeted
Jame Abraham Jul 12
Amazing story of an Argentinean doctor who came to for training .. ended up changing the history of medicine... According to him 'We' is more important than 'I.' In medicine, the advances are always the result of many efforts accumulated over the years."
Reply Retweet Like